✦ LIBER ✦

Vaccination of patients with liver disease: Who, when, and how

✍ Scribed by Thiel, D.H. Van

Publisher: Wiley (John Wiley & Sons)
Year: 1998
Tongue: English
Weight: 70 KB
Volume: 4
Category: Article
ISSN: 1074-3022
DOI: 10.1002/lt.500040213

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B vaccination of patients with

Hepatitis B vaccination of patients with chronic liver disease

✍ Keeffe, Emmet B. ;Krause, David S. 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 29 KB 👁 1 views

De novo hepatitis B infection after liver transplantation, in spite of its low prevalence as found by Fabia et al, 1 is of major concern, especially for infected patients and their families. More follow-up time is needed to assess the real impact in morbidity, mortality, and economic costs. Althoug

Recurrent disease in patients with liver

Recurrent disease in patients with liver transplantation: When does it occur and how can we be sure?

✍ David H. Van Thiel; Judy S. Gavaler 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB

Safety and immunogenicity of hepatitis A

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

✍ Emmet B. Keeffe; Sten Iwarson; Brian J. McMahon; Karen L. Lindsay; Raymond S. Ko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

Acute hepatitis A superimposed on chronic liver disease (CLD) has been associated with severe or fulminant hepatitis. An open, multicenter study was performed to compare the safety and immunogenicity of an inactivated hepatitis A vaccine in patients with CLD with that in healthy subjects. A secondar

Safety and immunogenicity of inactivated

Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease

✍ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Wang, Yuan-Jen; Chang, Full-Young; Lo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

The safety and immunogenicity of inactivated hepatitis A vaccine was evaluated in patients with chronic liver disease. Sixty hepatitis A virus antibody (anti-HAV) seronegative patients with chronic liver disease (56 chronic hepatitis B and four chronic hepatitis C) and from 17 to 47 years of age rec

Pneumococcal Vaccination: The Response o

Pneumococcal Vaccination: The Response of Patients with Alcoholic Liver Cirrhosis

✍ Mauro Pirovino; Eva Lydick; Peter J. Grob; Stephan Arrenbrecht; Josef Altorfer; 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB

Patients with cirrhosis have an increased risk of dying from pneumococcal pneumonia. Their immunological response to pneumococcal vaccination is not known. We compared the antibody response to challenge with a 14-valent purified pneumococcal polysaccharide vaccine in 15 patients with biopsy-proven a

Long-term follow-up of patients with alc

Long-term follow-up of patients with alcoholic liver disease who underwent hepatic transplantation

✍ Everson, G ;Bharadhwaj, G ;House, R ;Talamantes, M ;Bilir, B ;Shrestha, R ;Kam, 📂 Article 📅 1997 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 197 KB 👁 2 views